By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Estrogens > Ogen 1.25
Estrogens

Ogen 1.25

https://themeditary.com/drug/ogen-1-25-2596.html
Medically Reviewed by Oluni Odunlami, MD TheMediTary.Com | Reviewed: Jul 13, 2023  Additional Content by TheMediTary.Com

Generic name: estropipate [ es-troe-pip-ate ]

Drug class: Estrogens

Availability: Discontinued

Pregnancy & Lactation: Risk data available

Brand names: Estropipate

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Ogen 1.25?

Ogen 1.25 is a form of estrogen, a female sex hormone produced by the ovaries. Estrogen is necessary for many processes in the body.

Ogen 1.25 is used to treat menopause symptoms such as hot flashes and vaginal changes, and to prevent osteoporosis (bone loss) in menopausal women. This medicine is also used to replace estrogen in women with ovarian failure or other conditions that cause a lack of natural estrogen in the body.

Ogen 1.25 may also be used for purposes not listed in this medication guide.

Warnings

You should not use Ogen 1.25 if you have: undiagnosed vaginal bleeding, liver disease, if you will have major surgery, or if you have ever had a heart attack, a stroke, a blood clot, or cancer of the breast, uterus/cervix, or vagina.

Do not use if you are pregnant.

Ogen 1.25 may increase your risk of developing a condition that may lead to uterine cancer. Report any unusual vaginal bleeding right away.

Using Ogen 1.25 can increase your risk of blood clots, stroke, heart attack, or cancer of the breast, uterus, or ovaries. Ogen 1.25 should not be used to prevent heart disease, stroke, or dementia.

How should I use Ogen 1.25

Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose. Use the medicine exactly as directed.

Ogen 1.25 may increase your risk of developing a condition that may lead to uterine cancer. Your doctor may prescribe a progestin to help lower this risk. Report any unusual vaginal bleeding right away.

Your doctor should check your progress on a regular basis to determine whether you should continue this treatment. Self-examine your breasts for lumps on a monthly basis, and have regular mammograms while using Ogen 1.25.

If you need major surgery or will be on long-term bed rest, you may need to stop using Ogen 1.25 for a short time. Any doctor or surgeon who treats you should know that you are using Ogen 1.25.

Store this medication at room temperature away from moisture and heat.

Detailed Ogen 1.25 dosage information
Ogen 1.25 Dosage information (more detail)

Before Taking

You should not use Ogen 1.25 if you are allergic to it, or if you have:

  • unusual vaginal bleeding that has not been checked by a doctor;

  • liver disease;

  • a history of heart attack, stroke, or blood clot; or

  • a history of hormone-related cancer, or cancer of the breast, uterus/cervix, or vagina.

Do not use Ogen 1.25 if you are pregnant. Tell your doctor right away if you become pregnant during treatment.

Using Ogen 1.25 can increase your risk of blood clots, stroke, or heart attack. You are even more at risk if you have high blood pressure, diabetes, high cholesterol, if you are overweight, or if you smoke.

Ogen 1.25 should not be used to prevent heart disease, stroke, or dementia, because this medicine may actually increase your risk of developing these conditions.

Tell your doctor if you have ever had:

  • a hysterectomy;

  • heart disease;

  • liver problems, or jaundice caused by pregnancy or taking hormones;

  • a thyroid disorder;

  • gallbladder disease;

  • kidney disease;

  • asthma;

  • epilepsy or other seizure disorder;

  • migraine headaches;

  • lupus;

  • endometriosis or uterine fibroid tumors;

  • high levels of calcium in your blood; or

  • porphyria (a genetic enzyme disorder that causes symptoms affecting the skin or nervous system).

Using Ogen 1.25 may increase your risk of cancer of the breast, uterus, or ovaries. Talk with your doctor about this risk.

Ogen 1.25 can slow breast milk production. Tell your doctor if you are breast-feeding.

What happens if I miss a dose?

Take the medicine as soon as you can, but skip the missed dose if it is almost time for your next dose. Do not take two doses at one time.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using Ogen 1.25?

Avoid smoking. It can greatly increase your risk of blood clots, stroke, or heart attack while using Ogen 1.25.

Grapefruit may interact with Ogen 1.25 and lead to unwanted side effects. Avoid the use of grapefruit products.

Ogen 1.25 side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Ogen 1.25 may cause serious side effects. Call your doctor at once if you have:

  • heart attack symptoms--chest pain or pressure, pain spreading to your jaw or shoulder, nausea, sweating;

  • signs of a stroke--sudden numbness or weakness (especially on one side of the body), sudden severe headache, slurred speech, problems with vision or balance;

  • signs of a blood clot--sudden vision loss, stabbing chest pain, feeling short of breath, coughing up blood, pain or warmth in one or both legs;

  • swelling or tenderness in your stomach;

  • jaundice (yellowing of the skin or eyes);

  • memory problems, confusion, unusual behavior;

  • unusual vaginal bleeding, pelvic pain;

  • a lump in your breast; or

  • high levels of calcium in your blood--nausea, vomiting, constipation, increased thirst or urination, muscle weakness, bone pain, lack of energy.

Common side effects of Ogen 1.25 may include:

  • headache;

  • vaginal itching or discharge, changes in your menstrual periods, breakthrough bleeding;

  • bloating, stomach cramps, nausea, vomiting;

  • breast pain;

  • thinning scalp hair; or

  • fluid retention (swelling, rapid weight gain).

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Ogen 1.25 Side Effects

What other drugs will affect Ogen 1.25?

Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.

Other drugs may affect Ogen 1.25, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

More about Ogen 1.25 (Estropipate [ es-troe-pip-ate ])

Dosage information
Ogen 1.25 Side Effects
During pregnancy
Estropipate Prescribing Information
Drug images
Side effects
Drug class: Estrogens

Related treatment guides

Postmenopausal Symptoms
Atrophic Vaginitis
Hypoestrogenism
Oophorectomy
Primary Ovarian Failure
Osteoporosis
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by